Zihlschlacht Rehabilitation Clinic Appointed as the First DIH Center of Excellence in Switzerland [Yahoo! Finance]
FRESENIUS SE S/ADR (FSNUY)
NASDAQ:AMEX Investor Relations:
fresenius.com/index
Company Research
Source: Yahoo! Finance
reality (“VR”) technology provider in the rehabilitation and human performance industry, today announced that the Zihlschlacht Rehabilitation Clinic, founded in 1891 as a sanatorium, has been appointed as the first DIH Center of Excellence in Switzerland. Located on the Swiss side of Lake Constance, the clinic is renowned for its leadership in treating neurological diseases and its pioneering efforts in neurorehabilitation and research. The DIH Center of Excellence program recognizes strategic partners that showcase best practices in rehabilitation robotics while demonstrating how DIH therapy solutions contribute to successful patient outcomes. In addition, appointed Centers of Excellence play a crucial role in the ongoing development of advanced rehabilitation technologies. As a member of the VAMED Switzerland Group, Rehaklinik Zihlschlacht has been dedicated to the neurorehabilitation of stroke patients and the treatment of neurological diseases such as Parkinson's and multiple
Show less
Read more
Impact Snapshot
Event Time:
FSNUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FSNUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FSNUY alerts
High impacting FRESENIUS SE S/ADR news events
Weekly update
A roundup of the hottest topics
FSNUY
News
- Bulk Paclitaxel Strategic Industry Report 2024: Rising Global Cancer Incidence Throws the Spotlight on Paclitaxel Demand - Forecasts to 2030 [Yahoo! Finance]Yahoo! Finance
- Fresenius beats Q2 view on strong unit performance, cost savings [Yahoo! Finance]Yahoo! Finance
- Fresenius Continues its Biopharma Momentum with Launch of Subcutaneous Formulation of Tyenne® (tocilizumab-aazg) in the United StatesBusiness Wire